Ligand Pharmaceuticals prices \$400 million convertible notes to support strategic growth, strengthen balance sheet, and pursue potential acquisition opportunities. #LigandPharma #ConvertibleNotes #BiotechFinance https://meyka.com/blog/ligand-pharmaceuticals-announces-400-million-convertible-notes-pricing/

Pitney Bowes secures $200 million through convertible senior notes offering to support corporate initiatives and strengthen financial flexibility. #PitneyBowes #FinanceNews #ConvertibleNotes https://meyka.com/blog/pitney-bowes-announces-200-million-pricing-for-convertible-senior-notes-offering/